Drugmaker GSK calls for at least two years' Brexit transition

LONDON (Reuters) - Britain's pharmaceutical industry needs at least two years' transition to cope with the impact of the country leaving the European Union, the chief executive of GlaxoSmithKline said on Wednesday.